DMK PHARMACEUTICALS CORPORATION Retained Earnings
DMK PHARMACEUTICALS CORPORATION had Retained Earnings of -$323.47 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-14
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$323.47M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$322.08M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$313.51M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$304.56M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-09-30 | -$323.47M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$322.08M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | -$313.51M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$304.56M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | -$301.24M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$296.84M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | -$288.44M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$278.09M 10-K · filed 2023-03-16 | |
| 2021-09-30 | -$269.31M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | -$256.95M 10-Q · filed 2021-11-22 | |
| 2021-03-31 | -$247.64M 10-Q · filed 2021-11-22 | |
| 2020-12-31 | -$229.91M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$212.05M 10-K · filed 2021-04-15 | -$211.34M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$200.69M 10-K · filed 2021-04-15 | -$203.85M 10-Q · filed 2020-08-17 |
| 2020-03-31 | -$187.77M 10-K · filed 2021-04-15 | -$192.59M 10-Q · filed 2020-05-18 |
| 2019-12-31 | -$180.52M 10-K · filed 2021-04-15 | -$182.31M 10-K · filed 2020-03-30 |
| 2019-09-30 | -$176.63M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$169.63M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$161.90M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$153.00M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$140.19M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$131.32M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$121.62M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$114.00M 10-K · filed 2019-03-15 | |
| 2017-09-30 | -$105.97M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$99.20M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$94.23M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$88.46M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$87.79M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$81.14M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$75.43M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$69.02M 10-K · filed 2017-03-30 | |
| 2015-09-30 | -$65.38M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$62.24M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | -$58.59M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | -$55.45M 10-K · filed 2016-03-23 | |
| 2014-09-30 | -$51.14M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$49.01M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | -$46.13M 10-KT · filed 2015-03-26 | |
| 2013-12-31 | -$44.58M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$39.05M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$39.02M 10-Q · filed 2013-08-19 | |
| 2013-03-31 | -$37.98M 10-K · filed 2014-06-23 | |
| 2012-12-31 | -$36.34M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | -$34.37M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$33.51M 10-Q/A · filed 2012-08-17 | |
| 2012-03-31 | -$30.78M 10-K · filed 2013-07-03 | |
| 2011-12-31 | -$29.58M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$28.57M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$27.11M 10-Q · filed 2011-08-15 | |
| 2011-03-31 | -$25.87M 10-K · filed 2012-06-29 |